All News

Found 3,475 articles

• ImmunoGen, Inc. Announces Clinical And Preclinical Data Presentations At Upcoming 56th American Society of Hematology Annual Meeting And Exposition

  11/25/2014

• Immunomedics, Inc. Presents Clinical Data On Novel Antibody-Drug Conjugates For Solid Cancer Therapy

  11/21/2014

• Immunomedics, Inc. Presents Clinical Data On Novel Antibody-Drug Conjugates For Solid Cancer Therapy

  11/20/2014

• ImmunoGen, Inc. Again Named One Of The Boston Globe’s Top Places To Work

  11/13/2014

• Stemline Therapeutics, Inc. Reports Third Quarter 2014 Financial Results And Provides Corporate Update

  11/12/2014

• Sorrento Therapeutics, Inc. To Present At The 2014 Stifel Healthcare Conference

  11/12/2014

• Progenics Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results

  11/7/2014

• Immunomedics, Inc. Announces First Quarter Fiscal 2015 Results And Clinical Program Developments

  11/6/2014

• Genmab A/S Moves Cancer Drug Pact To Novartis AG From GlaxoSmithKline

  11/4/2014

• Immunomedics, Inc. Provides Update On Phase 2 Study Of Isactuzumab Govitecan In Patients With Diverse Metastatic Solid Cancers

  10/30/2014

• Innate Pharma Presents Two Posters On Proprietary BTG-ADC Technology At The World ADC Summit

  10/28/2014

• Mersana Therapeutics, Inc. And Takeda Enter Commercial License Agreement For Novel Fleximer® Antibody-Drug Conjugate

  10/27/2014

• Mersana Therapeutics, Inc. And Takeda Pharmaceutical Co. Ltd. Enter Commercial License Agreement For Novel Fleximer® Antibody-Drug Conjugate

  10/27/2014

• Glythera Unveils ADC Cysteine Linker Technology

  10/24/2014

• ImmunoGen, Inc. Reports First Quarter Fiscal Year 2015 Financial Results

  10/24/2014

• SSF's Sutro Biopharma Forges $1 Billion+ And Option To Buy Pact With Celgene

  10/23/2014

• New Class of MassCONNECT Startups Chosen Nixon Peabody LLP And Eli Lilly and Company Sponsor

  10/22/2014

• Immunomedics, Inc. To Present Updated Clinical Results With Solid-Tumor Antibody-Drug Conjugates At Upcoming Conferences

  10/22/2014

• Hanson Wade Release: Upcoming World Antibody-Drug Conjugate (ADC) Meeting and Awards in San Diego Highlight California's Growing Cancer Therapeutics Hub

  10/22/2014

• Immunomedics, Inc. Announces European Orphan Drug Designation For Isactuzumab Govitecan For Pancreatic Cancer Treatment

  10/20/2014